Compare Baxter International Inc (BAX) vs Fox Corp Class A (FOXA) Price & Performance

Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.

BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.

FOXA trades at $55.9, up 3.29% today, with a bearish technical signal but strong fundamental performance including three consecutive quarterly earnings beats. Revenue grew to $16.3B in 2025, with net income margin expanding to 13.88%. The company's acquisition of Roku for $22 billion marks a strategic pivot into streaming distribution, though it introduces leverage risk.

The outlook is mixed: analyst consensus targets $67.80 (21% upside) with a 50/50 buy/hold split, but 2026 forecasts show declining cash flow and earnings. Key risks include integration challenges from the Roku deal and streaming competition. Upside hinges on successful execution of the new strategy and advertising momentum.